Literature DB >> 10542213

Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for rho GTPases.

G Schmidt1, U M Goehring, J Schirmer, M Lerm, K Aktories.   

Abstract

Bordetella dermonecrotic toxin (DNT) causes the deamidation of glutamine 63 of Rho. Here we identified the region of DNT harboring the enzyme activity and compared the toxin with the cytotoxic necrotizing factor 1, which also deamidates Rho. The DNT fragment (DeltaDNT) covering amino acid residues 1136-1451 caused deamidation of RhoA at glutamine 63 as determined by mass spectrometric analysis and by the release of ammonia. In the presence of dansylcadaverine or ethylenediamine, DeltaDNT caused transglutamination of Rho. Deamidase and transglutaminase activities were blocked in the mutant proteins Cys(1292) --> Ala, His(1307) --> Ala, and Lys(1310) --> Ala of DeltaDNT. Deamidation and transglutamination induced by DeltaDNT blocked intrinsic and Rho- GTPase-activating protein-stimulated GTPase activity of RhoA. DeltaDNT deamidated and transglutaminated Rac and Cdc42 in the absence and presence of ethylenediamine, respectively. Modification of Rho proteins by DeltaDNT was nucleotide-dependent and did not occur with GTPgammaS-loaded GTPases. In contrast to cytotoxic necrotizing factor, which caused the same kinetics of ammonia release in the absence and presence of ethylenediamine, ammonia release by DeltaDNT was largely increased in the presence of ethylenediamine, indicating that DeltaDNT acts primarily as a transglutaminase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10542213     DOI: 10.1074/jbc.274.45.31875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Localization of functional domains of the mitogenic toxin of Pasteurella multocida.

Authors:  G D Pullinger; R Sowdhamini; A J Lax
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 2.  Targeting of the actin cytoskeleton by insecticidal toxins from Photorhabdus luminescens.

Authors:  Alexander E Lang; Gudula Schmidt; Joel J Sheets; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-11-12       Impact factor: 3.000

Review 3.  Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Future Microbiol       Date:  2010-08       Impact factor: 3.165

Review 4.  Bacterial protein toxins that modify host regulatory GTPases.

Authors:  Klaus Aktories
Journal:  Nat Rev Microbiol       Date:  2011-06-16       Impact factor: 60.633

Review 5.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

6.  Epitope mapping of monoclonal antibodies capable of neutralizing cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli.

Authors:  K C Meysick; M Mills; A D O'Brien
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Receptor-stimulated transamidation induces activation of Rac1 and Cdc42 and the regulation of dendritic spines.

Authors:  Zhen Mi; Tuda Si; Khushboo Kapadia; Qian Li; Nancy A Muma
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

8.  Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin.

Authors:  G Schmidt; U M Goehring; J Schirmer; S Uttenweiler-Joseph; M Wilm; M Lohmann; A Giese; G Schmalzing; K Aktories
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Transglutaminase in Receptor and Neurotransmitter-Regulated Functions.

Authors:  Nancy A Muma
Journal:  Med One       Date:  2018-12-05

Review 10.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.